CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Open-market buy President and CEO bought 20,000 shares at $3.29 ($65,884)
- 4 Open-market buy Chief Financial Officer bought 24,700 shares at $4.15 ($102,409)
- 4 Open-market buy President and CEO bought 10,000 shares at an average $4.40 ($43,950)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 4 Gift President and CEO gave 20,000 shares (gift)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 20 of 30 · 584 filings